Published in Obesity and Diabetes Week, February 26th, 2007
These results were presented at the 11th Annual Drug Delivery Partnerships Conference held in Las Vegas, Nevada, In a glucose-clamp study in normal subjects, Altea Therapeutics achieved constant insulin delivery at therapeutic levels over a 12-hour patch application period.
The data show efficient delivery of the applied dose of insulin and demonstrate favorable pharmacodynamics of transdermal insulin delivery when compared to a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week